BAUSCH + LOMB CORP (BLCO) Fundamental Analysis & Valuation

NYSE:BLCO • CA0717051076

Current stock price

15.37 USD
-0.52 (-3.27%)
At close:
15.27 USD
-0.1 (-0.65%)
After Hours:

This BLCO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BLCO Profitability Analysis

1.1 Basic Checks

  • BLCO had positive earnings in the past year.
  • In the past year BLCO had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
  • BLCO had a positive operating cash flow in 4 of the past 5 years.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of BLCO (-2.57%) is better than 69.84% of its industry peers.
  • BLCO's Return On Equity of -5.58% is fine compared to the rest of the industry. BLCO outperforms 70.37% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.23%, BLCO is in the better half of the industry, outperforming 67.72% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is significantly below the industry average of 9.31%.
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROIC 1.23%
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • BLCO has a Operating Margin of 3.69%. This is in the better half of the industry: BLCO outperforms 68.78% of its industry peers.
  • In the last couple of years the Operating Margin of BLCO has declined.
  • BLCO has a better Gross Margin (59.81%) than 61.38% of its industry peers.
  • In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 59.81%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1

2. BLCO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
  • BLCO has more shares outstanding than it did 1 year ago.
  • BLCO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BLCO has a worse debt to assets ratio.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.85, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.85, BLCO perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
  • BLCO has a Debt/Equity ratio of 0.78. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.78, BLCO is not doing good in the industry: 69.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.85
ROIC/WACC0.12
WACC10.25%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO has a Current ratio of 1.55. This is in the lower half of the industry: BLCO underperforms 73.55% of its industry peers.
  • BLCO has a Quick Ratio of 1.04. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.04, BLCO is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.04
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. BLCO Growth Analysis

3.1 Past

  • BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.35%.
  • BLCO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.47%.
  • The Revenue has been growing by 8.38% on average over the past years. This is quite good.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%

3.2 Future

  • BLCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.28% yearly.
  • The Revenue is expected to grow by 5.41% on average over the next years.
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue Next Year7.01%
Revenue Next 2Y6.29%
Revenue Next 3Y5.98%
Revenue Next 5Y5.41%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0.5 1 1.5 2

4

4. BLCO Valuation Analysis

4.1 Price/Earnings Ratio

  • BLCO is valuated quite expensively with a Price/Earnings ratio of 30.74.
  • Compared to the rest of the industry, the Price/Earnings ratio of BLCO indicates a somewhat cheap valuation: BLCO is cheaper than 73.02% of the companies listed in the same industry.
  • BLCO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.88.
  • A Price/Forward Earnings ratio of 19.03 indicates a rather expensive valuation of BLCO.
  • BLCO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 79.37% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. BLCO is around the same levels.
Industry RankSector Rank
PE 30.74
Fwd PE 19.03
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLCO is valued a bit cheaper than 76.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.98
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BLCO's earnings are expected to grow with 40.86% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y47.88%
EPS Next 3Y40.86%

0

5. BLCO Dividend Analysis

5.1 Amount

  • No dividends for BLCO!.
Industry RankSector Rank
Dividend Yield 0%

BLCO Fundamentals: All Metrics, Ratios and Statistics

BAUSCH + LOMB CORP

NYSE:BLCO (3/27/2026, 8:04:00 PM)

After market: 15.27 -0.1 (-0.65%)

15.37

-0.52 (-3.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners10.27%
Inst Owner Change3.1%
Ins Owners0.48%
Ins Owner Change17.19%
Market Cap5.46B
Revenue(TTM)5.10B
Net Income(TTM)-360.00M
Analysts71.58
Price Target18.83 (22.51%)
Short Float %6.93%
Short Ratio6.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-10.76%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-90.21%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)-43.92%
EPS beat(12)8
Avg EPS beat(12)-25.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.49%
PT rev (3m)7.6%
EPS NQ rev (1m)-28.97%
EPS NQ rev (3m)-46.1%
EPS NY rev (1m)0.36%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.73%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 30.74
Fwd PE 19.03
P/S 1.07
P/FCF N/A
P/OCF 19.28
P/B 0.85
P/tB N/A
EV/EBITDA 16.98
EPS(TTM)0.5
EY3.25%
EPS(NY)0.81
Fwd EY5.26%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)0.8
OCFY5.19%
SpS14.37
BVpS18.16
TBVpS-4.48
PEG (NY)0.5
PEG (5Y)N/A
Graham Number14.29
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROCE 1.55%
ROIC 1.23%
ROICexc 1.27%
ROICexgc 4.04%
OM 3.69%
PM (TTM) N/A
GM 59.81%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
ROICexc(3y)1.38%
ROICexc(5y)1.81%
ROICexgc(3y)4.6%
ROICexgc(5y)6.09%
ROCE(3y)1.7%
ROCE(5y)2.22%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y-11.42%
ROICexc growth 3Y-14.77%
ROICexc growth 5Y-9.61%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 8.28
Cap/Depr 82.9%
Cap/Sales 6.84%
Interest Coverage 0.49
Cash Conversion 46.47%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.04
Altman-Z 0.85
F-Score3
WACC10.25%
ROIC/WACC0.12
Cap/Depr(3y)65.67%
Cap/Depr(5y)57.94%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%
Revenue Next Year7.01%
Revenue Next 2Y6.29%
Revenue Next 3Y5.98%
Revenue Next 5Y5.41%
EBIT growth 1Y-7.39%
EBIT growth 3Y-8.57%
EBIT growth 5Y-6.91%
EBIT Next Year65.28%
EBIT Next 3Y27.94%
EBIT Next 5Y20.35%
FCF growth 1Y-11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3Y-6.39%
OCF growth 5Y-11.52%

BAUSCH + LOMB CORP / BLCO Fundamental Analysis FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.